![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Wanbury Limited Vashi, Navi Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Diphenhydramine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-285 - Rev 00
This Chemical Type CEP, issued on March 22, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 23 associated with this CEP further emphasizes